According to a recent LinkedIn post from Artera, the company is set to appear at the ViVE 2026 conference alongside Hanger, Inc.’s VP of Patient & Employee Experience, Carrie Davis. The session is described as focusing on Hanger’s progression from exploratory use of AI to deployment of AI agents for patient access, developed in collaboration with Artera.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights that the discussion, titled “Win the AI Race: Lessons on Deploying Agents for Patient Access,” will take place in the Data Innovation Theater at ViVE. This positioning suggests Artera is emphasizing its role in practical AI agent deployment for care experience workflows rather than purely experimental AI, which may appeal to health systems seeking near-term operational impact.
For investors, the collaboration with Hanger, Inc. may signal growing commercial traction and validation of Artera’s AI capabilities within established healthcare organizations. Visibility at a sector event such as ViVE could support Artera’s business development pipeline and reinforce its positioning in the competitive healthcare AI and patient engagement market.
If the partnership cases presented at the conference translate into replicable deployment models, Artera could see an expanding addressable market among providers looking to automate and streamline patient access. However, the post does not provide details on contract scope, revenue impact, or deployment scale, so the financial implications remain uncertain and will depend on conversion of interest into larger rollouts and multi-year agreements.